(Q33287810)

English

Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

0 references

type 2 diabetes

0 references

quality of life

1 reference

based on heuristic

inferred from title

Kristian Wahlbeck

object named as

Kristian Wahlbeck

2

0 references

Johan G. Eriksson

object named as

Johan G Eriksson

3

0 references

Maria Paile-Hyvärinen

1

object named as

Maria Paile-Hyvärinen

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

15 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

BMC Family Practice

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

15 June 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1471-2296-8-34

0 references

Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and Other Newer Antidepressant Agents in Adult Primary Care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914073

21 June 2018

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914073

21 June 2018

Antidepressant interactions with warfarin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914073

21 June 2018

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914073

21 June 2018

Sertraline in coexisting major depression and diabetes mellitus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914073

21 June 2018

Acute angle closure glaucoma associated with paroxetine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914073

21 June 2018

Prevalence of depression in adults with diabetes. An epidemiological evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914073

21 June 2018

The hospital anxiety and depression scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914073

21 June 2018

Incidence, prevalence and risk factors for non-insulin-dependent diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914073

21 June 2018

Fluoxetine in the treatment of obese type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-8-34

21 January 2018

Subthreshold psychiatric disorders in primary care: prevalence and associated characteristics.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-8-34

21 January 2018

The RAND 36-Item Health Survey 1.0.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-8-34

21 January 2018

Effect of weight loss on glucose disposal in obese and obese diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17570858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine treatment of the obese diabetic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17570858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17570858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/17570858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized double-blind clinical trial of fluoxetine in obese diabetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17570858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2296-8-34

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33287810&oldid=1857316692"